InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-18.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Chrousos Phaedra, Directrice. Officer active across 1 company, notably Vanda Pharmaceuticals Inc.. Aggregated, 8 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €66k. Activity tracked since 10 June 2021. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
41,600 shares0Common StockSEC:0001193125-26-261811:0
21,887 shares0Common StockSEC:0000950170-24-064669:0
17,307 shares0Common StockSEC:0001209191-23-036275:0
12,006 shares0Common StockSEC:0001209191-22-038446:0
2,075 shares@ US$19.340850.0% of flowCommon StockSEC:0001209191-21-040615
2,075 shares@ US$19.34080.0088% mcap50.0% of flowCommon StockSEC:0001209191-21-040615:0
5,000 shares0Common StockSEC:0001209191-21-040236
5,000 shares0Common StockSEC:0001209191-21-040236:0
8 of 8 declarations
About Chrousos Phaedra
Phaedra Chrousos is a Director at Vanda Pharmaceuticals Inc. She contributes to corporate governance and strategy for the company. As a board member, she participates in strategic decision-making that influences Vanda's direction. Her expertise in the pharmaceutical sector allows her to make significant contributions.
